No Data
No Data
Express News | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights
Leerink Partners Initiates Akebia Therapeutics(AKBA.US) With Buy Rating, Announces Target Price $7
Express News | Akebia Therapeutics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $7
$AKBA Stock Is up 8% Today. Here's What We See in Our Data.
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
74398752 : hold don't chase the market just wait for the dust to settle download stocktwits app and follow AKBA board. Good luck